GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adventa Bhd (XKLS:7191) » Definitions » EV-to-EBIT

Adventa Bhd (XKLS:7191) EV-to-EBIT : -10.91 (As of May. 08, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Adventa Bhd EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Adventa Bhd's Enterprise Value is RM95.57 Mil. Adventa Bhd's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was RM-8.76 Mil. Therefore, Adventa Bhd's EV-to-EBIT for today is -10.91.

The historical rank and industry rank for Adventa Bhd's EV-to-EBIT or its related term are showing as below:

XKLS:7191' s EV-to-EBIT Range Over the Past 10 Years
Min: -65.05   Med: 17.15   Max: 92.38
Current: -10.91

During the past 13 years, the highest EV-to-EBIT of Adventa Bhd was 92.38. The lowest was -65.05. And the median was 17.15.

XKLS:7191's EV-to-EBIT is ranked worse than
100% of 457 companies
in the Medical Devices & Instruments industry
Industry Median: 20.72 vs XKLS:7191: -10.91

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Adventa Bhd's Enterprise Value for the quarter that ended in Sep. 2023 was RM70.28 Mil. Adventa Bhd's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was RM-8.76 Mil. Adventa Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -12.46%.


Adventa Bhd EV-to-EBIT Historical Data

The historical data trend for Adventa Bhd's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adventa Bhd EV-to-EBIT Chart

Adventa Bhd Annual Data
Trend Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.39 -5.40 35.98 19.76 -19.50

Adventa Bhd Quarterly Data
Jul18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.39 -19.50 -14.21 -9.35 -8.02

Competitive Comparison of Adventa Bhd's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Adventa Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adventa Bhd's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adventa Bhd's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Adventa Bhd's EV-to-EBIT falls into.



Adventa Bhd EV-to-EBIT Calculation

Adventa Bhd's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=95.567/-8.758
=-10.91

Adventa Bhd's current Enterprise Value is RM95.57 Mil.
Adventa Bhd's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-8.76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adventa Bhd  (XKLS:7191) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Adventa Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 ) =EBIT / Enterprise Value (Q: Sep. 2023 )
=-8.758/70.27880125
=-12.46 %

Adventa Bhd's Enterprise Value for the quarter that ended in Sep. 2023 was RM70.28 Mil.
Adventa Bhd's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-8.76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adventa Bhd EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Adventa Bhd's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Adventa Bhd (XKLS:7191) Business Description

Traded in Other Exchanges
N/A
Address
No. 21, Jalan Tandang 51/205A, Seksyen 51, Petaling Jaya, SGR, MYS, 46050
Adventa Bhd is engaged in the business of medical services and related supplies manufacturing. The company's segments include Healthcare Business, Warehousing provider, and Corporate. It generates maximum revenue from the Healthcare Business segment. The healthcare business segment comprises the supply of healthcare and related products and services to hospitals, healthcare centres, and pharmacies. Previously, it also included the renal dialysis business which are both for home and centre-based treatments, serving both the domestic and export markets. Geographically, it derives a majority of revenue from Malaysia.

Adventa Bhd (XKLS:7191) Headlines

No Headlines